Cooper Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Cooper Financial Group's NVO Position: Q2 2026 in Review
Cooper Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,524 shares — an estimated $240K sold.
Cooper Financial Group first reported a position in NVO in Q1 2023 and held it in 12 quarters. The position peaked at $1.47M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Cooper Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Cooper Financial Group sold 6,524 Novo Nordisk shares in Q2 2026, an estimated $240K.
- Cooper Financial Group first reported a position in Novo Nordisk in Q1 2023 and held it in 12 quarters.
- Cooper Financial Group's Novo Nordisk position peaked at $1.47M in Q1 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.